Milan wants to be the city where the longevity revolution begins. Here’s what that actually means.

Every few years, a conference emerges that is trying to do something genuinely different — not just convene experts but shift the way an entire conversation is framed. The Milan Longevity Summit, returning to Allianz MiCo on 20–23 May 2026, is making that bet. Whether it succeeds is worth watching closely.

The summit’s core argument is this: longevity is not a health topic. It is an urban planning topic, an agricultural topic, a financial topic, a cultural topic, a mental health topic, and a climate topic — all at once.

The organisers call this One Health, and they have built a four-day programme around it that spans everything from Nobel Prize-winning neuroscience to regenerative farming, from psychedelic-assisted therapy to the economics of the five-generation workforce. If that sounds unfocused, it isn’t.

The connective tissue is a single uncomfortable question: what does it actually take to build a society where people live well for longer, not just survive longer?

That distinction matters more than it might seem. The longevity space has a serious credibility problem. On one end, you have Silicon Valley biohackers injecting young blood and taking 50 supplements before breakfast. On the other you have academic conferences where the same researchers present the same findings to the same audience every year. MLS is trying to occupy a third space: serious science, applied urgency, and cross-sector scale. The speaker lineup suggests it has earned the right to try.

The number that stops you cold

Lars Hartenstein, co-founder of the McKinsey Health Institute and one of the confirmed speakers, published a report in 2025 with a finding worth sitting with: addressing even half of the age-related disease burden globally could add $2 trillion to GDP. Not over a century. Not in some theoretical model. In measurable, near-term economic terms.

That figure reframes the entire conversation. Longevity stops being a lifestyle category — something sold alongside anti-ageing creams and expensive supplements — and becomes one of the most significant economic levers available to governments, investors, and businesses. It is the reason a conference on aging attracts people from Cisco, McKinsey, the World Bank, PeakBridge VC, and the Salk Institute to the same stage. They are not there for philosophical reasons. They are there because the numbers are starting to look serious.

What actually happens at Allianz MiCo

The main conference runs across 4 stages over 4 days, with 250+ speakers and an expected 1,000+ attendees. But what makes MLS structurally different from most events is what happens beyond the main stage.

There is an Innovation Expo where startups and scaleups meet investors and corporates across all 12 sectors. A startup pitch competition for early-stage ventures. A Catalyst Club for emerging founders to access mentorship and networks. Workshops where participants don’t just discuss roadmaps — they write them.

Then there are the Longevity Houses — and these are genuinely interesting. Rather than keeping the conversation inside a conference hall, the organisers are deploying immersive installations across Milan’s neighbourhoods and public squares. Interactive, sensory environments where citizens who will never attend a paid conference can engage physically with questions about food, mental health, urban design, and the future of ageing. It is an unusual move for an event of this kind, and it reflects a conviction the organisers have articulated clearly: the gap between knowing what needs to change and actually changing it is mostly a storytelling and access problem, not a knowledge problem.

The speaker who might surprise you most

The headliner is Thomas C. Südhof — Nobel Laureate in Physiology or Medicine (2013) at Stanford Medicine — whose work on synaptic transmission is foundational to understanding neurological and psychiatric diseases. His presence anchors the scientific credibility of the event.

But the speaker worth watching is Carlo Ratti from MIT’s Senseable City Lab, who chairs the World Economic Forum’s Global Future Council on Cities. Ratti’s argument — that the city is the most powerful health intervention available — runs through the entire summit like a thread. How you design a neighbourhood, where you put the parks, how walkable the streets are, whether there are third places where different generations mix: these are longevity interventions. They just don’t get marketed as such.

Other confirmed names span the full range of the programme’s ambition.

• David Furman (Buck Institute) has commercialised AI-powered biological ageing clocks into multiple spin-offs.
• Jennifer Dowd Beam (Oxford) is investigating why life expectancy is stalling in the UK and US — arguably the most important public health question in wealthy democracies right now.
• Susana Muhamad, who presided over COP16 as Colombia’s Environment Minister, connects the planetary dimension.
• John Fullerton (Capital Institute), the architect of Regenerative Economics, challenges the financial assumptions that underpin most investment in this space.
• Tina Woods (International Institute of Longevity) has literally co-founded a longevity rave — because she believes joy and community are as important to healthspan as any clinical intervention.
• Pawel Swieboda, former Director General of the Human Brain Project, brings the neurotechnology governance angle.
• Matteo Ward, FAO Food Hero and host of the Italian docuseries Junk, bridges fashion, food, and sustainability in a way that makes both industries uncomfortable.
• Nadav Berger (PeakBridge VC) represents the investment community that is quietly building serious positions in food and longevity tech.

The Vatican question

After Milan, the summit moves to Vatican City on 25–26 May for the Vatican Longevity Summit — two days focused on the ethical frontiers of longevity and artificial intelligence.

This is the part of the programme that deserves more attention than it usually gets, because the question it poses is genuinely unsettling: if we can extend human life significantly, should we? And if we do, who gets access? The Vatican setting is not just atmospheric. It deliberately places the most profound questions about extending human life within a framework that takes dignity, equity, and human meaning seriously — a necessary counterweight to an industry that sometimes talks about living to 150 with the enthusiasm of someone selling a fitness app.

Why Milan

The choice of Milan as host is not incidental. The city has been positioning itself as a European hub for life sciences, design, and innovation for years — and the summit’s expanding city-wide activation model reflects that ambition. The patronage of the Comune di Milano formalises a relationship that the event has been building since its first edition. The event is organised by Brain Circle Italia and supported by SoLongevity.

For anyone working in healthtech, longevity, climate, food, finance, or the broader innovation landscape, this is the European event of the year in its category. Not because it has all the answers — it doesn’t — but because it is asking the right questions, in the right city, at a moment when the answers are starting to matter economically.